Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

Rapidly expanding systemic treatment options, combined with improved screening, diagnostic, surgical, and radiotherapy techniques, have led to improved survival outcomes for many cancers over time. However, these overall survival gains have disproportionately benefited patients in high-income countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Brooke E., Sullivan, Richard, Peto, Richard, Abubakar, Bello, Booth, Christopher, Werutsky, Gustavo, Adams, Cary, Saint-Raymond, Agnes, Fleming, Thomas R., Lyerly, Kim, Gralow, Julie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
SPECIAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645408/
https://www.ncbi.nlm.nih.gov/pubmed/37944089
http://dx.doi.org/10.1200/GO.23.00294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645408/
https://www.ncbi.nlm.nih.gov/pubmed/37944089
http://dx.doi.org/10.1200/GO.23.00294

Ejemplares similares